CPUL1 is a TrxR inhibitor that exhibits antiproliferative and anti-metastatic activities in A549 cells; it suppresses TrxR1 enzyme activity, thereby inducing ROS-mediated ERK/JNK signaling and modulating epithelial-mesenchymal transition (EMT); it shows enhanced efficacy when used in combination with α-Lipoic Acid (HY-N0492) or Dithiodipropionic acid (HY-W014395).